Neonatal sepsis due to Weeksella virosa

Anuradha Mokkapati

Abstract


Weeksella virosa was previously included in group II f of CDC. We here present the Microbiological characteristics of the isolate from a case of neonatal sepsis at our center. The organism is a non-fermenter growing only on blood agar and not on Mac Conkey agar, oxidase and catalase positive, and negative for several other bio-chemical tests, except for indole with Ehrlich’s reagent. The isolate in the present case study was sensitive to aminoglycosides and β- lactams, and resistant to quinolones and carbapenems.


Keywords


Weeksella virosa, Non-Fermenter, Blood Agar

Full Text:

PDF

References


Jordi Reina, Jose Gil, Fransisco Salva, Joaquin Gomez and Pedro Alomar. Microbiological characteristics of Weeksella virosa (formerly CDC group IIf) isolated from the human genitor-urinary tract. Journal of Clinical Microbiology, October 1990; 28(10): 2357-2359.

B Holmes, A G Steigerwalt, R E Weaver, Don J Brenner. Weeksella virosa gen. nov. ,sp. nov. (formerly group IIf), found in human clinical specimens. In: Systematic and Applied Microbiology. Elsevier publications, October 1986; 8(3): 185-190.

Washington Winn Jr, Stephen Allen, William Janda, Elmer Koneman. The non-fermentative Gram Negative Bacilli. In: Koneman’s colour atlas and textbook of Microbiology, 6th edition. Lippincott, Williams and Wilkins publications, 2006: 309-375.

A K Slenker, B D Hess, D L Jungkind, J A Desimone. A fatal case of Weeksella virosa sepsis and a review of literature. Journal of Clinical Microbiology, 2002; 18(2): 123-128.

S K Meherwal, Neelam Taneja, S K Sharma, Meera Sharma. Complicated nosocomial UTI caused by non-fermenters. Indian Journal of Urology, 2002; 18(2): 123-128.

Mark D Faber, Ramon del Bustol, Cosme Cruzl, Eugene Merger. Response of Weeksella virosa Peritonitis to Imipenem Cilastin. Advances in Peritoneal Dialysis, 1991; 7: 133-134.

Mansula Manogaran, Thomas Marnejon and Erdal Sarac. Pneumonia and sepsis due to Weeksella virosa in an immune-compromised patient. Infectious Diseases in Clinical Practice, September 2004; 12(5): 286-287.